Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bellus Health Inc
(NQ:
BLU
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bellus Health Inc
< Previous
1
2
3
4
Next >
Why Is ContraFect (CFRX) Stock Down 14% Today?
April 18, 2023
ContraFect (CFRX) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq Exchange and undergoing a rally yesterday.
Via
InvestorPlace
Why Is Bellus Health (BLU) Stock Up 98% Today?
April 18, 2023
Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).
Via
InvestorPlace
Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
April 18, 2023
Gainers Super League Gaming, Inc. (NASDAQ: SLGG) jumped 119.8% to $0.9408 in pre-market trading. LandVault and Super League disclosed a strategic partnership to provide brands with scalable solutions...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 18, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday!
Via
InvestorPlace
BELLUS Health Shares Slide On Public Offering Of Shares In Canada And US
July 13, 2022
Via
Benzinga
BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program
July 12, 2022
Via
Benzinga
BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
April 18, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
April 18, 2023
Via
Benzinga
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation
April 05, 2023
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Reports Year 2022 Financial Results and Business Highlights
March 21, 2023
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting
February 08, 2023
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
November 14, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
November 10, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting
October 10, 2022
From
BELLUS Health Inc.
Via
Business Wire
Expert Ratings for BELLUS Health
September 30, 2022
Over the past 3 months, 4 analysts have published their opinion on BELLUS Health (NASDAQ:BLU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
BELLUS Health to Present at the H.C. Wainwright Global Investment Conference
September 06, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022
August 22, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
August 10, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States
July 18, 2022
From
BELLUS Health Inc.
Via
Business Wire
Here's Why BELLUS Health Shares Are Diving Lower Today
July 14, 2022
BELLUS Health Inc (NASDAQ: BLU) shares are trading lower by 10.80% to $9.00 Thursday morning after the company priced an offering of 16,540,541 shares at a price of $9.25 per share.
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
U.S. Stock Futures Down Ahead Of Bank Earnings, Producer Price Index
July 14, 2022
Pre-open movers
Via
Benzinga
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
July 13, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
July 13, 2022
From
BELLUS Health Inc.
Via
Business Wire
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
July 12, 2022
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Participate in the William Blair Biotech Focus Conference
July 05, 2022
From
BELLUS Health Inc.
Via
Business Wire
The Week In Charts: How To Make Money While Waiting For Core Trend Trades
July 02, 2022
The real money is in the longer-term core trend trades. However, sometimes those opportunities can be few and far between. This is especially true in a bear market.
Via
Talk Markets
4 Biotech Stocks With Bright Prospects To Buy Amid Recovery
June 11, 2022
New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for...
Via
Talk Markets
BELLUS Health to Participate in the Jefferies Healthcare Conference
June 01, 2022
From
BELLUS Health Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.